"Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway for small molecule & peptide drug programs. Cutting through silos across a range of drug development capabilities, we help pharma and biotech companies get new therapies to patients, fast."

During the past decade, Quotient Sciences Miami conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Quotient Sciences Miami" #1 sponsor was "Pfizer" with 5 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Satsuma Pharmaceuticals, Inc." with 2 trials sponsored, "Altor BioScience" with 1 trials sponsored and "Angion Biomedica Corp" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Quotient Sciences Miami" #1 collaborator was "Quotient Sciences" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Quotient Sciences Miami" are "Healthy" (5 trials), "Healthy Participants" (4 trials), "Migraine" (2 trials), "Migraine With Aura" (2 trials) and "Migraine Without Aura" (2 trials). Many other conditions were trialed in "Quotient Sciences Miami" in a lesser frequency.

Most popular intervention types in "Quotient Sciences Miami" are "Drug" (21 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Dihydroergotamine" (2 trials), "PF-06651600" (2 trials), "AC-OLE-01-VA" (1 trials) and "ALT-803" (1 trials). Other intervention names were less common.

The vast majority of trials in "Quotient Sciences Miami" are 15 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Quotient Sciences Miami". 1 are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Quotient Sciences Miami, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Quotient Sciences Miami, 21 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".